These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3012349)

  • 1. Vaccine engineering. Violation of rules alleged.
    Palca J
    Nature; 1986 May 15-21; 321(6067):190. PubMed ID: 3012349
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of recombination on the genetic stability of pseudorabies vaccine virus.
    Visser N
    Dev Biol Stand; 1995; 84():97-104. PubMed ID: 7796973
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant-derived modified-live herpesvirus vaccines.
    Kit S
    Adv Exp Med Biol; 1989; 251():219-36. PubMed ID: 2558526
    [No Abstract]   [Full Text] [Related]  

  • 4. Researcher reprimanded for pseudorabies test.
    Crawford M
    Science; 1986 Nov; 234(4777):667-8. PubMed ID: 3022375
    [No Abstract]   [Full Text] [Related]  

  • 5. New developments in the construction of safer and more versatile pseudorabies virus vaccines.
    Mettenleiter TC
    Dev Biol Stand; 1995; 84():83-7. PubMed ID: 7796971
    [No Abstract]   [Full Text] [Related]  

  • 6. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudorabies virus infections in pigs. Role of viral proteins in virulence, pathogenesis and transmission.
    Mulder WA; Pol JM; Gruys E; Jacobs L; De Jong MC; Peeters BP; Kimman TG
    Vet Res; 1997; 28(1):1-17. PubMed ID: 9172836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
    Kit S; Sheppard M; Ichimura H; Kit M
    Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
    Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
    Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is recombination of PRV vaccine strains a real problem?
    Visser N; Rziha HJ
    Acta Vet Hung; 1994; 42(2-3):183-93. PubMed ID: 7810411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of Aujeszky's disease virus recombinants from experimentally co-infected swine.
    Dangler CA; Henderson LM; Deaver RE; Bowman LA
    Acta Vet Hung; 1994; 42(2-3):209-12. PubMed ID: 7810414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of live pseudorabies virus vaccines.
    Kimman TG; Gielkens AL; Glazenburg K; Jacobs L; de Jong MC; Mulder WA; Peeters BP
    Dev Biol Stand; 1995; 84():89-96. PubMed ID: 7796972
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenicity of bivalent vaccine for reproductive failure of swine induced by pseudorabies virus and porcine parvovirus.
    Mengeling WL; Gutekunst DE; Pirtle EC; Paul PS
    Am J Vet Res; 1981 Apr; 42(4):600-3. PubMed ID: 6277213
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of Aujeszky disease control using marker vaccines].
    Stegeman JA
    Tijdschr Diergeneeskd; 1995 Sep; 120(17):502-4. PubMed ID: 7570555
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity of vector DNA vaccine constructs of pseudorabies virus immediate early gene (IE180) in mice and swine.
    Garmendia AE; Chang S; Tulman ER; Rompato G; Bu J
    Ann N Y Acad Sci; 1998 Jun; 849():485-9. PubMed ID: 9668518
    [No Abstract]   [Full Text] [Related]  

  • 16. Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain.
    Moormann RJ; de Rover T; Briaire J; Peeters BP; Gielkens AL; van Oirschot JT
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1591-5. PubMed ID: 2165138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constancy of Aujeszky's field virus antibody titres in sows repeatedly vaccinated with a gI-negative vaccine.
    Hopp W; Jungblut R
    Acta Vet Hung; 1994; 42(2-3):409-11. PubMed ID: 7810439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of pseudorabies virus from three large swine herds achieved by management intervention and use of a vaccine with a deletion for glycoprotein I.
    Lehman JR; Weigel RM; Hall WF; Taft AC
    J Am Vet Med Assoc; 1994 Dec; 205(11):1581-7. PubMed ID: 7730129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E.
    Firkins LD; Weigel RM; Biehl LG; Hahn EC
    Am J Vet Res; 1997 Sep; 58(9):976-84. PubMed ID: 9285001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccines against Aujeszy's disease].
    Toma B
    Dev Biol Stand; 1982; 52():407-13. PubMed ID: 6299851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.